Back

Long-term outcomes of beta-blocker use in elderly patients without left ventricular systolic dysfunction after percutaneous coronary intervention for acute myocardial infarction

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in myocardial infarction Beta-Blockers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Assistant Professor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
The effect of discontinuing long-term beta-blockers following acute myocardial infarction in optimally treated, stable patients without heart failure - a Danish, nationwide cohort study
Doctor A. Halili (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Influence of cholesterol levels on NSAID-associated risks after myocardial infarction: a nationwide population-based cohort study
Mr M. Basem Abdallah (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Empagliflozin in patients with myocardial infarction: an updated meta-analysis
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry
Doctor P. Paolisso (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study
Doctor A. Aimo (Pisa, IT)
Abstract Slides

Access the full session

Session thumbnail
Pharmacotherapy in myocardial infarction

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
thumbnail
Congress Presentation
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction
thumbnail
Congress Presentation
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources